TY  - JOUR
AU  - Jiménez Fonseca, Paula
AU  - Carmona-Bayonas, Alberto
AU  - Hernández, Raquel
AU  - Custodio, Ana
AU  - Cano, Juana Maria
AU  - Lacalle, Alejandra
AU  - Echavarria, Isabel
AU  - Macias, Ismael
AU  - Mangas, Monserrat
AU  - Visa, Laura
AU  - Buxo, Elvira
AU  - Álvarez Manceñido, Felipe
AU  - Viudez, Antonio
AU  - Pericay, Carles
AU  - Azkarate, Aitor
AU  - Ramchandani, Avinash
AU  - López, Carlos
AU  - Martinez de Castro, Eva
AU  - Fernández Montes, Ana
AU  - Longo, Federico
AU  - Sánchez Bayona, Rodrigo
AU  - Limón, Maria Luisa
AU  - Diaz-Serrano, Asun
AU  - Martin Carnicero, Alfonso
AU  - Arias, David
AU  - Cerdà, Paula
AU  - Rivera, Fernando
AU  - Vieitez, Jose Maria
AU  - Sánchez Cánovas, Manuel
AU  - Garrido, M
AU  - Gallego, J
PY  - 2017
DO  - 10.1038/bjc.2017.245
UR  - http://hdl.handle.net/10668/11463
T2  - British journal of cancer
AB  - The choice of chemotherapy in HER2-negative gastric cancer is based on centre's preferences and adverse effects profile. No schedule is currently accepted as standard, nor are there any factors to predict response, other than HER2 status. We seek to...
LA  - en
KW  - Anthracyclines
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Chile
KW  - Cisplatin
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Receptor, ErbB-2
KW  - Registries
KW  - Spain
KW  - Stomach Neoplasms
KW  - Taxoids
KW  - Treatment Outcome
TI  - Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
TY  - research article
VL  - 117
ER  -